B. Lynne Parshall

Track

Insider profile

Currently holds positions in Akcea Therapeutics Inc, CardioDynamics International Corp, Ionis Pharmaceuticals Inc and Cytokinetics Inc

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 39% 68% 82%
Transactions
22 5% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairperson of the Board Akcea Therapeutics Inc Dec. 16, 2019 -
Director CardioDynamics International Corp July 1, 2005 -
Director Ionis Pharmaceuticals Inc Jan. 10, 2020 -
Independent Director Cytokinetics Inc Feb. 7, 2013 -
Director, Senior Strategic Advisor Ionis Pharmaceuticals Inc Jan. 1, 2018 - Jan. 10, 2020
Director Akcea Therapeutics Inc Jan. 1, 2015 - Dec. 16, 2019
Chief Operating Officer, Corporate Secretary, Director Ionis Pharmaceuticals Inc Jan. 1, 2013 - Dec. 1, 2017
Director Regulus Therapeutics Inc Jan. 2, 2009 - June 10, 2015
Chief Financial Officer, Chief Operating Officer, Secretary, Director Ionis Pharmaceuticals Inc Dec. 14, 2007 - Dec. 1, 2012
B. Lynne Parshall's trades of Cytokinetics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-01 2026-06-01
S Sale
20,470 -23.2%
427.70
US$4,810,667 		20,470 -23.2% 427.70 US$4,810,667
2026-04-17 2026-04-15
PlS Planned sale
38,798 +17.5%
183.66
US$3,087,833 		38,798 +17.5% 183.66 US$3,087,833
2026-04-17 2026-04-15
PlS Planned sale
97,496 +7.6%
123.42
US$1,657,023 		97,496 +7.6% 123.42 US$1,657,023
2026-03-02 2026-03-02
S Sale
5,000 -21.8%
61.21
US$306,050 		5,000 -21.8% 61.21 US$306,050
2026-03-02 2026-03-02
PrS Proposed sale
10,000
62.22
US$622,200 		10,000 62.22 US$622,200
2026-02-13 2026-02-11
PlS Planned sale
5,000 -8.2%
82.72
US$413,588 		5,000 -8.2% 82.72 US$413,588
2026-02-11 2026-02-11
PrS Proposed sale
10,000
82.74
US$827,400 		10,000 82.74 US$827,400
2025-11-19 2025-11-19
PrS Proposed sale
5,000
66.16
US$330,800 		5,000 66.16 US$330,800
2025-11-19 2025-11-19
S Sale
5,000 -17.9%
64.73
US$323,650 		5,000 -17.9% 64.73 US$323,650
2025-10-16 2025-10-15
PlS Planned sale
5,000 -7.5%
71.74
US$358,722 		5,000 -7.5% 71.74 US$358,722
2025-10-15 2025-10-15
PrS Proposed sale
5,000
71.74
US$358,722 		5,000 71.74 US$358,722
2025-09-04 2025-09-02
PlS Planned sale
9,250 -12.2%
51.49
US$476,282 		9,250 -12.2% 51.49 US$476,282
2025-09-04 2025-09-02
PlS Planned sale
10,750 -12.5%
50.42
US$542,015 		10,750 -12.5% 50.42 US$542,015
2025-09-02 2025-09-02
PrS Proposed sale
20,000
50.91
US$1,018,296 		20,000 50.91 US$1,018,296
2025-08-08 2025-08-06
PlS Planned sale
400 -0.5%
42.63
US$17,051 		400 -0.5% 42.63 US$17,051
2025-08-08 2025-08-06
PlS Planned sale
4,600 -5.0%
41.87
US$192,595 		4,600 -5.0% 41.87 US$192,595
2025-08-06 2025-08-06
PrS Proposed sale
10,000
41.93
US$419,292 		10,000 41.93 US$419,292
2024-09-09 2024-09-09
PrS Proposed sale
5,000
54.92
US$274,582 		5,000 54.92 US$274,582
2024-09-09 2024-09-09
S Sale
5,000 -19.5%
54.92
US$274,600 		5,000 -19.5% 54.92 US$274,600
2024-08-26 2024-08-26
PrS Proposed sale
5,000
57.26
US$286,288 		5,000 57.26 US$286,288
2024-08-26 2024-08-26
S Sale
5,000 -19.5%
57.26
US$286,300 		5,000 -19.5% 57.26 US$286,300
2024-08-12 2024-08-12
PrS Proposed sale
5,000
55.20
US$276,007 		5,000 55.20 US$276,007
2024-08-12 2024-08-12
S Sale
5,000 -19.5%
55.20
US$276,000 		5,000 -19.5% 55.20 US$276,000
2024-07-31 2024-07-29
S Sale
5,000 -19.5%
59.84
US$299,200 		5,000 -19.5% 59.84 US$299,200
2024-07-29 2024-07-29
PrS Proposed sale
5,000
59.84
US$299,217 		5,000 59.84 US$299,217
2024-07-16 2024-07-15
S Sale
5,000 -19.5%
55.82
US$279,100 		5,000 -19.5% 55.82 US$279,100
2024-07-15 2024-07-15
PrS Proposed sale
5,000
55.82
US$279,082 		5,000 55.82 US$279,082
2024-07-01 2024-07-01
PrS Proposed sale
5,000
54.22
US$271,094 		5,000 54.22 US$271,094
2024-07-01 2024-07-01
S Sale
5,000 -19.5%
54.22
US$271,100 		5,000 -19.5% 54.22 US$271,100
2024-06-17 2024-06-17
PrS Proposed sale
5,000
52.55
US$262,728 		5,000 52.55 US$262,728
2024-06-17 2024-06-17
S Sale
5,000 -19.5%
52.55
US$262,750 		5,000 -19.5% 52.55 US$262,750
2024-06-04 2024-06-03
S Sale
5,000 -24.3%
48.64
US$243,200 		5,000 -24.3% 48.64 US$243,200
2024-06-03 2024-06-03
PrS Proposed sale
5,000
48.64
US$243,200 		5,000 48.64 US$243,200
2023-12-28 2023-12-28
S Sale
42,525 -34.0%
50.19
US$2,134,223 		42,525 -34.0% 50.19 US$2,134,223
2023-12-28 2023-12-27
S Sale
50,000 -37.7%
50.23
US$2,511,515 		50,000 -37.7% 50.23 US$2,511,515
2023-12-28 2023-12-26
S Sale
25,113 -23.3%
51.46
US$1,292,390 		25,113 -23.3% 51.46 US$1,292,390
2023-12-27 2023-12-26
PrS Proposed sale
117,638
51.50
US$6,058,357 		117,638 51.50 US$6,058,357
2023-10-12 2023-09-26
PrS Proposed sale
10,000
45.13
US$451,268 		10,000 45.13 US$451,268
2023-09-28 2023-09-26
PlS Planned sale
10,000 -10.8%
45.13
US$451,268 		10,000 -10.8% 45.13 US$451,268
2023-09-26 2023-09-26
PrS Proposed sale
10,000
45.13
US$451,268 		10,000 45.13 US$451,268
2022-09-01 2022-09-01
PlS Planned sale
30,296 -75.2%
52.79
US$1,599,326 		30,296 -75.2% 52.79 US$1,599,326
2021-11-05 2021-11-05
PlS Planned sale
2,798 -35.9%
40.00
US$111,920 		2,798 -35.9% 40.00 US$111,920
2021-11-05 2021-11-05
PlS Planned sale
4,166 -45.5%
40.00
US$166,640 		4,166 -45.5% 40.00 US$166,640
2021-11-05 2021-11-05
PlS Planned sale
4,032 -44.6%
40.00
US$161,280 		4,032 -44.6% 40.00 US$161,280
2021-11-05 2021-11-05
PlS Planned sale
20,000 -80.0%
40.00
US$800,000 		20,000 -80.0% 40.00 US$800,000